Eli Lilly Halts Work on Heart Drug After Poor Performance in Clinical Trial
Drug maker Eli Lilly & Co. announced on Monday that it had halted work on an experimental heart drug, after the drug, evacetrapib, failed to perform well in a clinical study. Lilly said Monday it was discontinuing development of evacetrapib, which was designed to ward off heart attacks and other cardiovascular problems by … [Read more...] about Eli Lilly Halts Work on Heart Drug After Poor Performance in Clinical Trial
Scios Heart Drug Curbed
Scios Heart Drug Natrecor Not Approved By FDA. Fremont biotechnology firm Scios Inc. is taking the first of a series of steps to curb prescribing of its heart drug Natrecor for uses not approved by the Food and Drug Administration. The company, a unit of Johnson & Johnson, had been accused of promoting those unapproved uses by … [Read more...] about Scios Heart Drug Curbed
Heart Drug Guide Indicating Risks Misses Deadline
Heart Drug Potential Risks. Millions of U.S. patients taking a potentially risky heart medication may not get the promised government warnings with their prescriptions until the end of the year, a drug manufacturer said this week. The drug, amiodarone, is widely used by doctors to treat heart rhythm disorders such as atrial … [Read more...] about Heart Drug Guide Indicating Risks Misses Deadline
Heart Drug Serious Side Effects
Heart Drug May Cause Abnormal Heart Rhythms. A drug commonly used for short-term treatment of worsening heart failure in hospitalized patients may cause dangerously low blood pressure and abnormal heart rhythms, researchers found. The findings suggest that the drug, milrinone, should be reserved for patients who do not respond to … [Read more...] about Heart Drug Serious Side Effects
